The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol
Open accessAbstract
Resveratrol, naringenin and naringin are naturally occurring flavonoids in grapes and grapefruits. The anti‐inflammatory effects of these flavonoids have been well documented, but the mechanism is poorly characterized. High concentration of NO are produced by inducible NO synthase (iNOS) in inflammation, and the prevention of the expression of iNOS may be an important anti‐inflammatory mechanism. In this study, the effects of these flavonoids on the induction of NO synthase (NOS) in RAW 264.7 cells activated with bacterial lipopolysaccharide (LPS, 50 ng ml−1) were investigated. Resveratrol was found strongly to inhibit NO generation in activated macrophages, as measured by the amount of nitrite released into the culture medium, and resveratrol strongly reduced the amount of cytosolic iNOS protein and steady state mRNA levels. However, the inhibitory abilities of naringenin were lower, and the inhibitory abilities of naringin were almost negligible. In electrophoretic mobility shift assays, the activation of NFκB induced by LPS for 1 h was inhibited by resveratrol (30 μ M). Furthermore, in immunoblotting analysis, cells treated with LPS plus resveratrol showed an inhibition of phosphorylation as well as degradation of IκBα, and a reduced nuclear content of NFκB subunits. The flavonoids may be of value for inhibiting the enhanced expression of iNOS in inflammation through down‐regulation of NFκB binding activity. British Journal of Pharmacology (1999) 126, 673–680; doi:10.1038/sj.bjp.0702357
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,941
Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 2×
“Of these transcription factors, only the activation of NFkB has been shown to mediate the enhanced expression of the iNOS gene in macrophages exposed to LPS (Xie et al., 1994).”
BackgroundRegulation of biosynthesis of nitric oxide.
Nathan, C., & Xie, Q. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36703-0 · Cited by 1,669
Stuehr, D. J., & Marletta, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7738 · Cited by 1,126
Cited by
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Dietary polyphenols and their biological significance
Han, X., Shen, T., & Lou, H. (2007) · International Journal of Molecular Sciences · doi:10.3390/i8090950 · Cited by 1,081
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
de la Lastra, C. A., & Villegas, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351156 · Cited by 740
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Comalada, M., Camuesco, D., Sierra, S., Ballester, I., Xaus, J., Gálvez, J., & Zarzuelo, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425778 · Cited by 647
Nuclear Factor κB Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory Mechanisms
Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., & Gerhäuser, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104794200 · Cited by 632
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Resveratrol: from grapevines to mammalian biology
Pervaiz, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0168rev · Cited by 520
Biological Effects of Resveratrol
Bhat, K. P. L., Kosmeder, J. W., & Pezzuto, J. M. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601317203567 · Cited by 507
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
Targeting NOX, iNOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals
Murakami, A., & Ohigashi, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.23161 · Cited by 478
The molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477
“Initial hypothesis suggested that Rsv might either reduce NF-κB nuclear presence [111] or interfere with the transcriptional activity [112].”
BackgroundCancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
Resveratrol: French Paradox Revisited
Catalgol, B., Batirel, S., Taga, Y., & Ozer, N. K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00141 · Cited by 449
“In electrophoretic mobility shift assays, the activation of NFκB induced by LPS was inhibited by resveratrol (Tsai et al., 1999).”
BackgroundDietary antioxidants in preventing atherogenesis
Kaliora, A. C., Dedoussis, G. V. Z., & Schmidt, H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.001 · Cited by 417
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Cancer Chemopreventive Activity of Resveratrol
BHAT, K. P. L., & PEZZUTO, J. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 398
Role of resveratrol in regulation of cellular defense systems against oxidative stress
Truong, V., Jun, M., & Jeong, W. (2018) · BioFactors · doi:10.1002/biof.1399 · Cited by 392
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 390
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
Gusman, J. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1111 · Cited by 388
Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties
Yoon, J.-H., & Baek, S. J. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.5.585 · Cited by 381
Chemistry and Biology of Resveratrol-Derived Natural Products
Keylor, M. H., Matsuura, B. S., & Stephenson, C. R. J. (2015) · Chemical Reviews · doi:10.1021/cr500689b · Cited by 366
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S., Leung, R. H. F., Ito, K., Russell, R. E. K., & Barnes, P. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00110.2004 · Cited by 361
Effective inhibition of MERS-CoV infection by resveratrol
Lin, S.-C., Ho, C.-T., Chuo, W.-H., Li, S., Wang, T. T., & Lin, C.-C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2253-8 · Cited by 358
ESPOSITO, E., ROTILIO, D., DIMATTEO, V, DIGIULIO, C., CACCHIO, M., & ALGERI, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 326
Youdim, K. A., Martin, A., & Joseph, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00329-4 · Cited by 312
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302
Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds
Nassiri‐Asl, M., & Hosseinzadeh, H. (2009) · Phytotherapy Research · doi:10.1002/ptr.2761 · Cited by 300
Lorenz, P., Roychowdhury, S., Engelmann, M., Wolf, G., & Horn, T. F. W. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.09.005 · Cited by 297
Lo, A.-H., Liang, Y.-C., Lin-Shiau, S.-Y., Ho, C.-T., & Lin, J.-K. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.983 · Cited by 292
Self-citationResveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J. Y., Dong, Y. X., Wang, J. M., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274
Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A., & Pandol, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10202 · Cited by 274
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Bolisetty, S., & Jaimes, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036306 · Cited by 273
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 269
Camuesco, D., Comalada, M., Rodríguez‐Cabezas, M. E., Nieto, A., Lorente, M. D., Concha, A., Zarzuelo, A., & Gálvez, J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705941 · Cited by 268
Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín-Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264
Jeong, W.-S., Kim, I.-W., Hu, R., & Kong, A.-N. T. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022413.43212.cf · Cited by 264
Afaq, F., Adhami, V. M., & Ahmad, N. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00014-5 · Cited by 262
Martı&#x;n, A. R., Villegas, I., La Casa, C., & de la Lastra, C. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.024 · Cited by 258
Leiro, J. M., Álvarez, E., Arranz, J. A., Siso, I. G., & Orallo, F. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00041-8 · Cited by 154
Ku, C. S., Pham, T. X., Park, Y., Kim, B., Shin, M. S., Kang, I., & Lee, J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.018 · Cited by 109
Menzies, F. M., Henriquez, F. L., Alexander, J., & Roberts, C. W. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04086.x · Cited by 90
DeMars, K. M., Yang, C., Castro-Rivera, C. I., & Candelario-Jalil, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.096 · Cited by 66
Benameur, T., Porro, C., Twfieg, M.-E., Benameur, N., Panaro, M. A., Filannino, F. M., & Hasan, A. (2023) · Brain Sciences · doi:10.3390/brainsci13081226 · Cited by 60
Metadata
- Authors
- Tsai, S., Lin‐Shiau, S., & Lin, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-02
- Volume
- 126
- Issue
- 3
- Pages
- 673-680
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2122390360
- Cited by
- 511
- References
- 33
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.